Mölnlycke Health Care
Zlatko Rihter is an accomplished executive with extensive experience in leadership roles across various companies. Currently serving as a Board Member at Sobi - Swedish Orphan Biovitrum AB (publ) since May 2024 and as CEO of Mölnlycke since November 2020, Zlatko Rihter has previously contributed as a Board Member for Malmö FF and Etac Group, and as CEO of CellaVision. Additional professional experience includes a position as Executive Vice President of Sales & Marketing at ORIGIO, President of GBU Chronic at Gambro, and Director of the Patient Handling Product Division at ArjoHuntleigh. Rihter's career began at Gambro, where significant impact was made as Vice President of the Renal Services Business Line. Zlatko Rihter holds a Master’s degree in Mechanical Engineering from The Faculty of Engineering at Lund University, earned between 1991 and 1996.
This person is not in any teams
This person is not in any offices
Mölnlycke Health Care
4 followers
Mölnlycke Health Care employs around 7,500 people and is owned by Investor AB. The company headquarters are in Gothenburg, Sweden and operate in 90 countries worldwide. Mölnlycke Health Care is a world-leading provider of single-use surgical and wound care products for customers, healthcare professionals and patients. Mölnlycke Health Caredevelop and bring to market innovative wound care and surgical products for use in a range of settings – from prevention through acute care to homecare. Mölnlycke Health Care solutions provide value for money, supported by clinical and health economic evidence.